These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34529400)

  • 1. Assessing
    Lanko K; Shi C; Patil S; Delang L; Matthijnssens J; Mirabelli C; Neyts J
    ACS Infect Dis; 2021 Oct; 7(10):2801-2806. PubMed ID: 34529400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in anti-EV-A71 drug development research.
    Wang S; Pang Z; Fan H; Tong Y
    J Adv Res; 2024 Feb; 56():137-156. PubMed ID: 37001813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C.
    Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X
    J Virol; 2021 May; 95(12):. PubMed ID: 33789997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanomastat exerts multi-targeted inhibitory effects on viral capsid dissociation and RNA replication in human enteroviruses.
    Lim TYM; Jaladanki CK; Wong YH; Yogarajah T; Fan H; Chu JJH
    EBioMedicine; 2024 Sep; 107():105277. PubMed ID: 39226680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Assessment of Combinations of Enterovirus Inhibitors against Enterovirus 71.
    Wang Y; Li G; Yuan S; Gao Q; Lan K; Altmeyer R; Zou G
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5357-67. PubMed ID: 27353263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The capsid binder Vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication.
    Tijsma A; Franco D; Tucker S; Hilgenfeld R; Froeyen M; Leyssen P; Neyts J
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6990-2. PubMed ID: 25199773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of dibucaine derivatives as novel potent enterovirus 2C helicase inhibitors: In vitro, in vivo, and combination therapy study.
    Tang Q; Xu Z; Jin M; Shu T; Chen Y; Feng L; Zhang Q; Lan K; Wu S; Zhou HB
    Eur J Med Chem; 2020 Sep; 202():112310. PubMed ID: 32619885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid.
    Sun L; Lee H; Thibaut HJ; Lanko K; Rivero-Buceta E; Bator C; Martinez-Gualda B; Dallmeier K; Delang L; Leyssen P; Gago F; San-Félix A; Hafenstein S; Mirabelli C; Neyts J
    PLoS Pathog; 2019 May; 15(5):e1007760. PubMed ID: 31071193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors.
    Hsieh CF; Jheng JR; Lin GH; Chen YL; Ho JY; Liu CJ; Hsu KY; Chen YS; Chan YF; Yu HM; Hsieh PW; Chern JH; Horng JT
    Emerg Microbes Infect; 2020 Dec; 9(1):1194-1205. PubMed ID: 32397909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products.
    Li G; Gao Q; Yuan S; Wang L; Altmeyer R; Lan K; Yin F; Zou G
    Antiviral Res; 2017 Jul; 143():85-96. PubMed ID: 28412182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71.
    Ho JY; Chern JH; Hsieh CF; Liu ST; Liu CJ; Wang YS; Kuo TW; Hsu SJ; Yeh TK; Shih SR; Hsieh PW; Chiu CH; Horng JT
    J Antimicrob Chemother; 2016 Jul; 71(7):1922-32. PubMed ID: 27098012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the proteostasis network during enterovirus infection: A feedforward mechanism for EV-A71 and EV-D68.
    Jheng JR; Chen YS; Horng JT
    Antiviral Res; 2021 Apr; 188():105019. PubMed ID: 33484748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct-acting antivirals and host-targeting strategies to combat enterovirus infections.
    Bauer L; Lyoo H; van der Schaar HM; Strating JR; van Kuppeveld FJ
    Curr Opin Virol; 2017 Jun; 24():1-8. PubMed ID: 28411509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 3D Human Intestinal Organoids as a Platform for EV-A71 Antiviral Drug Discovery.
    Masmoudi F; Santos-Ferreira N; Pajkrt D; Wolthers KC; DeGroot J; Vlaming MLH; Rocha-Pereira J; Buti L
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral effect in association with anti-apoptosis and anti-autophagy of repurposing formoterol fumarate dihydrate on enterovirus A71-infected neuronal cells.
    Jintana K; Prasertsopon J; Puthavathana P; Lerdsamran H
    Virus Res; 2022 Apr; 311():198692. PubMed ID: 35093474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants.
    Ianevski A; Frøysa IT; Lysvand H; Calitz C; Smura T; Schjelderup Nilsen HJ; Høyer E; Afset JE; Sridhar A; Wolthers KC; Zusinaite E; Tenson T; Kurg R; Oksenych V; Galabov AS; Stoyanova A; Bjørås M; Kainov DE
    Antiviral Res; 2024 Apr; 224():105842. PubMed ID: 38417531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71).
    Lalani S; Masomian M; Poh CL
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antivirals and vaccines for Enterovirus A71.
    Lin JY; Kung YA; Shih SR
    J Biomed Sci; 2019 Sep; 26(1):65. PubMed ID: 31481071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. dsRNA Binding Domain of PKR Is Proteolytically Released by Enterovirus A71 to Facilitate Viral Replication.
    Chang YH; Lau KS; Kuo RL; Horng JT
    Front Cell Infect Microbiol; 2017; 7():284. PubMed ID: 28702377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel capsid binder and PI4KIIIbeta inhibitors for EV-A71 replication inhibition.
    Tan YW; Yam WK; Kooi RJW; Westman J; Arbrandt G; Chu JJH
    Sci Rep; 2021 May; 11(1):9719. PubMed ID: 33958691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.